No Data
No Data
AI empowers the FDA! Drug approvals hit the 'fast-forward' button, and a large number of pharmaceutical companies may welcome a 'Gold' period.
The USA Food and Drug Administration (FDA) announced an accelerated plan on Thursday to fully implement AI applications across all subsidiary institutions by June 30, aiming to significantly expedite the approval process for new pharmaceuticals.
Hong Kong market quick review | The three major Indexes showed mixed results, with the Hang Seng Index up 0.13%; Machinery and Mainland Real Estate stocks performed well, new stock Boleton surged over 38%, MORIMATSU INTL rose nearly 6%; RADIANCE HLDGS inc
Network Technology stocks declined, XIAOMI-W fell by 2.81%, Alibaba-W dropped by 2.02%; Casinos and Gaming stocks generally rose, MELCO INT'L DEV increased by 4.73%, SANDS CHINA LTD rose by 2.67%; Pharmaceutical stocks weakened, GRANDPHARMA rose by 13.36%, 3SBIO fell by 6.62%.
Hong Kong Stock Afternoon Review | The three major indices had mixed performances, with the Hang Seng Index up by 0.49%; Chinese brokerages and Mainland Real Estate stocks were strong, with HOLLY FUTURES rising by over 56% and RADIANCE HLDGS increasing by
Network Technology stocks fell, XIAOMI-W dropped 2.62%, Alibaba-W fell 1.37%; Pharmaceutical stocks mostly declined, GRANDPHARMA rose 11.02%, 3SBIO fell 7.59%; Casinos and Gaming stocks increased, MELCO INT'L DEV rose 2.66%, WYNN MACAU rose 2.19%.
Lobbyist groups warn that Trump's drug pricing proposal could lead to a loss of 1 trillion dollars for the pharmaceutical industry.
Lobbying groups warn that USA President Donald Trump's new pharmaceutical pricing proposal could result in losses of up to 1 trillion dollars for pharmaceutical companies over the next decade.
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
The Pacific Securities: The Sector's profits improved significantly in Q1, and the pharmaceutical industry is expected to see a rapid increase in concentration.
The trend of increasing concentration in the pharmaceutical industry and the strong becoming stronger is expected to continue to strengthen.